CareDx, Inc. (CDNA) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $2.92B, a trailing price-to-earnings ratio of 50.9 and a free-cash-flow yield of 1.2%. Over the most recent reported fiscal year, revenue grew 13.8% and free cash flow per share grew 19.3%.